Search clinical trials for: Live attenuated rotavirus vaccine

Total 372 results

Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) (PNEU-PED-EU-2)

Pneumococcal Infections

Denmark, Finland, Italy, Norway, Sweden
Sanofi Pasteur, a Sanofi Company

Completed

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

Japanese Encephalitis | Measles | Rubella | Mumps

Taiwan
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

HIV Infections | Chickenpox

United States
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children

HIV Infections

United States
Sanofi Pasteur, a Sanofi Company

Recruiting

Dengvaxia US Pregnancy Registry (DNG00044)

Dengue Virus Infection

Puerto Rico
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

Tularemia

United States
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination

Hepatitis C

United States
University of Washington
Merck Sharp & Dohme LLC

Completed

Immune Response to Shingles Vaccination

Shingles

United States
PATH
Beijing Bio-Institute Biological Products Co., Ltd., formerly Beijing TiantanBio

Completed

Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine

Poliomyelitis

Kenya
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)

Herpes Zoster | Pneumococcal Infection
Seqirus
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Influenza | Influenza, Human | Influenza A Virus, H5N1 Subtype | Flu, Human | Flu, Avian

Australia, Germany, Italy
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)

Herpes Zoster
Sanofi Pasteur, a Sanofi Company

Recruiting

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (CORAL)

RSV Immunization

United States, Puerto Rico
Kenya Medical Research Institute
Merck Sharp & Dohme LLC; University of Washington

Completed

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

HPV Infection | HPV Vaccine | HIV-1-infection

Kenya
GlaxoSmithKline

Completed

Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants

Cervical Cancer | Precancerous Condition

Costa Rica
Federal Budgetary Research Institution State Research...

Completed

Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years

Smallpox | Monkeypox | Cowpox | Vaccinia Virus Infection

Russian Federation
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort (SLVP033)

Hepatitis A | Influenza | Healthy Adults | Typhoid

United States
Merck Sharp & Dohme LLC

Completed

Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056)

Varicella
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)

Herpes Zoster | Shingles
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX(R) Local Registration Trial (V211-019)

Varicella Virus Infection
Bavarian Nordic
Emergent BioSolutions

Completed

VAXCHORA Pediatric Study to Assess Safety and Immunogenicity

Cholera (Disorder)

United States
Merck Sharp & Dohme LLC
University of Colorado, Denver; Duke University

Completed

Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)

Herpes Zoster | Varicella-zoster Vaccine
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)

Herpes Zoster | Shingles
Shanghai Institute Of Biological Products

Completed

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

Vaccine | Immunotoxicity

China
Research Institute of Influenza, Russia
World Health Organization; Institute of Experimental Medicine, Russia

Completed

Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine

Influenza
PATH
Institute of Experimental Medicine, Russia; Microgen

Completed

Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine

Influenza

Russian Federation
GlaxoSmithKline

Completed

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Measles | Rubella | Mumps | Varicella

Finland, Germany, Poland, Greece
M.D. Anderson Cancer Center
Celgene Corporation

Terminated

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

Hematologic Disorder

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

Herpes Zoster
Sanofi

Completed

Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine

Japanese Encephalitis

Australia
PATH Vaccine Solutions
Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal...

Completed

Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine

Influenza

Bangladesh
Merck Sharp & Dohme LLC

Completed

A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)

Herpes Zoster
Aduro Biotech, Inc.
Incyte Corporation

Terminated

Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer (SEASCAPE)

Platinum-resistant Ovarian Cancer | Platinum-resistant Fallopian Cancer | Platinum-resistant Peritoneal Cancer

United States, Canada
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)

Shingles
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients With Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
CanSino Biologics Inc.

Recruiting

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)

Pertussis | Tetanus | Diphtheria

China
Belarusian Research Center for Pediatric Oncology...

Recruiting

DNA Vaccination Against Neuroblastoma

Relapsed Neuroblastoma

Belarus
Changchun BCHT Biotechnology Co.
Hu Bei province Center for Disease control and prevention; The Inner Mongolia...

Recruiting

Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine

Influenza Prevention

China
University of Maryland, Baltimore
PATH

Completed

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

Shigella

United States
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

Shingles
National Cancer Institute (NCI)

Active, not recruiting

Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial

Human Papillomavirus-Related Cervical Carcinoma

Costa Rica
Roswell Park Cancer Institute

Recruiting

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Pneumonia | Chronic Obstructive Pulmonary Disease | Lung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IB Lung Cancer AJCC v8

United States
U.S. Army Medical Research and Development Command

Completed

TDENV PIV and LAV Dengue Prime-boost Strategy

Dengue

United States
COL George Peoples, MD, FACS

Completed

Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer

Ovarian Cancer | Endometrial Cancer | Peritoneal Cancer | Fallopian Cancer

United States
Gradalis, Inc.

Completed

Salvage Ovarian FANG™ Vaccine + Carboplatinum

Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States
University of Maryland, Baltimore
PATH

Terminated

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

Shigella

United States
Centers for Disease Control and Prevention, China
Beijing Tiantan Biological Products Co., Ltd.

Completed

Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine

Measles | Rubella | Mumps | Adverse Event Following Immunisation

China
Merck Sharp & Dohme LLC

Completed

Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)

Condyloma Acuminata | Anogenital Human Papilloma Virus Infection
Washington University School of Medicine

Not yet recruiting

Evaluating the Human Immune Response to the JYNNEOS Vaccine

Virus Diseases | Vaccinia

United States

Search clinical trials for: Live attenuated rotavirus vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations